Clinical Trial Update: DDAVP vs. Exercise in Patients With Mild Hemophilia A [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing desmopressin (DDAVP) to exercise in patients with mild Hemophilia A without inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Mild Haemophilia A Without Inhibitor | Phase 4 | Status: UNKNOWN